Nihon Kohden BSM-3000 Bedside Monitor False Alarm Recall
Nihon Kohden recalls BSM-3000 Series Bedside Monitors with serial numbers 1613-1651 due to false "SpO2 Probe Failure" alarms. Affected units may display incorrect alerts.
Lower-risk recall
Due to software issue the device may give false "SpO2 Probe Failure" alarm
Contact the company
What happened, in plain English
Nihon Kohden is recalling certain BSM-3000 Series bedside monitors that may give false alarms about oxygen probe failure. This could cause unnecessary alerts and confusion in medical settings. Read more at govinfonow.com/recall/55293-nihon-kohden-bsm-3000-bedside-monitor-false-alarm-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/55293-nihon-kohden-bsm-3000-bedside-monitor-false-alarm-recall · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2025-2024
Cite this page
“Nihon Kohden BSM-3000 Bedside Monitor False Alarm Recall.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/55293-nihon-kohden-bsm-3000-bedside-monitor-false-alarm-recall. Based on FDA recall #Z-2025-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2025-2024%22&limit=1).
Why it’s dangerous
The device has a software issue that causes it to incorrectly signal an oxygen probe failure. This can lead to unnecessary alarms that might distract medical staff or cause confusion during patient monitoring.
Who’s affected
Healthcare facilities using the BSM-3000 Series monitors with serial numbers 1613-1651 are affected. Staff using these monitors for patient monitoring may see false alarms.
How to tell if you have this one
Check for serial numbers 1613, 1614, 1616, 1617, 1618, 1619, 1621, 1622, 1624, 1625, 1627, 1631, 1638, 1639, 1640, or 1651 on the monitor. The product is labeled as the Life Scope BSM-3000 Series Bedside Monitoring System.
- Brand
Nihon Kohden- Category
Medical device
What to do — step by step
Check for False Alarms
If the monitor displays a false "SpO2 Probe Failure" alarm, stop using it until the issue is resolved.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide distribution in the state of IA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 44 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2025-2024 (April 29, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2025-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.